G9298 – Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9298
- Long description
- Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
- Short description
- Eval risk vte card 30d prior
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
M5BSpecialist - psychiatry- Added
- January 1, 2014
- Last change
- January 1, 2015 – No change
Frequently asked questions
What is HCPCS code G9298?
G9298 is a HCPCS Level II code for patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke).
Does Medicare cover G9298?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9290 – Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
- G9291 – Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos
- G9292 – Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
- G9293 – Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
- G9294 – Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
- G9295 – Specimen site other than anatomic cutaneous location
- G9296 – Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure
- G9297 – Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given
- G9299 – Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)
- G9300 – Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)
- G9301 – Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet
- G9302 – Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given
- G9303 – Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given
- G9304 – Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant
- G9305 – Intervention for presence of leak of endoluminal contents through an anastomosis not required
- G9306 – Intervention for presence of leak of endoluminal contents through an anastomosis required
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.